{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T20:06:19Z","timestamp":1777752379489,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703014"],"award-info":[{"award-number":["81703014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004712","name":"Tianjin University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004712","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019065","name":"Tianjin Municipal Science and Technology Program","doi-asserted-by":"publisher","award":["20YDTPJC00950"],"award-info":[{"award-number":["20YDTPJC00950"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bioorg.2025.108687","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T02:39:53Z","timestamp":1749782393000},"page":"108687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Protac synthesized on the basis of azaflavonoid derivatives possesses favorable anti-hepatocellular carcinoma activity"],"prefix":"10.1016","volume":"163","author":[{"given":"Guoyang","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cen","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuou","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108687_bb0005","article-title":"New advances in the diagnosis and management of hepatocellular carcinoma","volume":"371","author":"Yang","year":"2020","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1016\/j.bioorg.2025.108687_bb0010","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","article-title":"Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN","volume":"72","author":"Morgan","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.bioorg.2025.108687_bb0015","series-title":"Risk of HBV reactivation during therapies for HCC: A systematic review, Hepatology (Baltimore, Md.)","first-page":"1257","volume":"75","author":"Papatheodoridi","year":"2022"},{"key":"10.1016\/j.bioorg.2025.108687_bb0020","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bioorg.2025.108687_bb0025","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bioorg.2025.108687_bb0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2025.108687_bb0035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12943-022-01575-z","article-title":"M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma","volume":"21","author":"Du","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2025.108687_bb0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ng0495-401","article-title":"In vivo amplification of the androgen receptor gene and progression of human prostate cancer","volume":"9","author":"Visakorpi","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bioorg.2025.108687_bb0045","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cell.2012.02.053","article-title":"Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer","volume":"149","author":"Duncan","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2025.108687_bb0050","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cbpa.2019.07.003","article-title":"Bifunctional chemical probes inducing protein-protein interactions","volume":"52","author":"Maniaci","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.108687_bb0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cell.2019.11.031","article-title":"Proteolysis-targeting chimeras as therapeutics and tools for biological discovery","volume":"181","author":"Burslem","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2025.108687_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2019.110452","article-title":"Targeting nuclear receptors with PROTAC degraders","volume":"493","author":"Flanagan","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bioorg.2025.108687_bb0065","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.fct.2005.01.019","article-title":"Toxicology and safety of anti-oxidant of bamboo leaves. Part 1: acute and subchronic toxicity studies on anti-oxidant of bamboo leaves","volume":"43","author":"Lu","year":"2005","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bioorg.2025.108687_bb0070","doi-asserted-by":"crossref","first-page":"678","DOI":"10.2174\/1871520620666200227091811","article-title":"A critical review on anticancer mechanisms of natural flavonoid Puerarin","volume":"20","author":"Murahari","year":"2020","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108687_bb0075","series-title":"Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease, Inflammation research: official journal of the European Histamine Research Society \u2026 [et al.]","first-page":"537","volume":"58","author":"Garc\u00eda-Lafuente","year":"2009"},{"key":"10.1016\/j.bioorg.2025.108687_bb0080","first-page":"536","article-title":"Glucosidase inhibition","volume":"64","author":"Puls","year":"1977","journal-title":"A new approach to the treatment of diabetes, obesity, and hyperlipoproteinaemia, Die Naturwissenschaften"},{"key":"10.1016\/j.bioorg.2025.108687_bb0085","doi-asserted-by":"crossref","first-page":"7218","DOI":"10.1016\/j.bmc.2009.08.056","article-title":"Synthesis and antioxidant properties of new chromone derivatives","volume":"17","author":"Gomes","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108687_bb0090","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1016\/j.bmcl.2012.05.086","article-title":"Synthesis and evaluation of novel 3a,9a-dihydro-1-ethoxycarbonyl-1-cyclopenteno[5,4-b]benzopyran-4-ones as antifungal agents","volume":"22","author":"Goel","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108687_bb0095","first-page":"2155","volume":"33","author":"Yang Jinhui","year":"2013","journal-title":"Total Synthesis and Antibacterial Activities of Four Natural Dual Prenylated Flavonoids"},{"key":"10.1016\/j.bioorg.2025.108687_bb0100","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ejpb.2014.03.011","article-title":"Nanoparticles generated by PEG-Chrysin conjugates for efficient anticancer drug delivery","volume":"87","author":"Zheng","year":"2014","journal-title":"European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V"},{"key":"10.1016\/j.bioorg.2025.108687_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124007","article-title":"Chrysin inhibits tumor promoter-induced MMP-9 expression by blocking AP-1 via suppression of ERK and JNK pathways in gastric cancer cells","volume":"10","author":"Xia","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2025.108687_bb0110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.fitote.2017.12.020","article-title":"Hyperattenins L and M, two new polyprenylated acylphloroglucinols with adamantyl and homoadamantyl core structures from Hypericum attenuatum","volume":"125","author":"Li","year":"2018","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bioorg.2025.108687_bb0115","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1002\/ptr.7104","article-title":"Quercetin as a protective agent for liver diseases: a comprehensive descriptive review of the molecular mechanism","volume":"35","author":"Zhao","year":"2021","journal-title":"Phytotherapy research: PTR"},{"key":"10.1016\/j.bioorg.2025.108687_bb0120","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejmech.2018.01.004","article-title":"Novel vitexin-inspired scaffold against leukemia","volume":"146","author":"Ling","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108687_bb0125","first-page":"1117","article-title":"Chemical structure","volume":"11","author":"Dre\u021bcanu","year":"2022","journal-title":"Sources and Role of Bioactive Flavonoids in Cancer Prevention: A Review"},{"key":"10.1016\/j.bioorg.2025.108687_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116837","article-title":"PROTAC unleashed: unveiling the synthetic approaches and potential therapeutic applications","volume":"279","author":"Pravin","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108687_bb0135","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.18632\/aging.102165","article-title":"The combination of lonafarnib and sorafenib induces cyclin D1 degradation via ATG3-mediated autophagic flux in hepatocellular carcinoma cells","volume":"11","author":"Wang","year":"2019","journal-title":"Aging"},{"key":"10.1016\/j.bioorg.2025.108687_bb0140","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/cbdd.13514","article-title":"Design and optimize N-substituted EF24 as effective and low toxicity NF-\u03baB inhibitor for lung cancer therapy via apoptosis-to-pyroptosis switch","volume":"94","author":"Chen","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2025.108687_bb0145","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13046-016-0378-z","article-title":"Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt\/\u03b2-catenin pathway in esophageal squamous cell carcinoma","volume":"35","author":"He","year":"2016","journal-title":"Journal of experimental & clinical cancer research: CR"},{"key":"10.1016\/j.bioorg.2025.108687_bb0150","first-page":"2180","article-title":"Silencing the expression of MTDH increases the radiation sensitivity of SKOV3 ovarian cancer cells and reduces their proliferation and metastasis","volume":"53","author":"Chen","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bioorg.2025.108687_bb0155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccr.2013.07.012","article-title":"A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis","volume":"24","author":"Kollmann","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioorg.2025.108687_bb0160","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1089\/ars.2018.7658","article-title":"Redox- and ligand binding-dependent conformational ensembles in the human apoptosis-inducing factor regulate its pro-life and cell death functions","volume":"30","author":"Villanueva","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bioorg.2025.108687_bb0165","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/jnci\/djz208","article-title":"Unraveling triple-negative breast Cancer tumor microenvironment heterogeneity: towards an optimized treatment approach","volume":"112","author":"Bareche","year":"2020","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bioorg.2025.108687_bb0170","series-title":"N-Alkylaminoferrocene-Based Prodrugs Targeting Mitochondria of Cancer Cells, Molecules (Basel, Switzerland)","volume":"25","author":"Reshetnikov","year":"2020"},{"key":"10.1016\/j.bioorg.2025.108687_bb0175","first-page":"532","article-title":"Bcl-2 proteins and mitochondria--specificity in membrane targeting for death","volume":"2011","author":"Lindsay","year":"1813","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioorg.2025.108687_bb0180","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ceb.2009.09.004","article-title":"Mitochondrial cell death effectors","volume":"21","author":"Brenner","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bioorg.2025.108687_bb0185","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1101\/gad.11.6.701","article-title":"The PI 3-kinase\/Akt signaling pathway delivers an anti-apoptotic signal","volume":"11","author":"Kennedy","year":"1997","journal-title":"Genes Dev."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682500567X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682500567X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:59:43Z","timestamp":1777463983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682500567X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":37,"alternative-id":["S004520682500567X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108687","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protac synthesized on the basis of azaflavonoid derivatives possesses favorable anti-hepatocellular carcinoma activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108687","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108687"}}